Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.120
-0.160 (-12.50%)
At close: Sep 26, 2025, 4:00 PM EDT
1.120
0.00 (-0.01%)
After-hours: Sep 26, 2025, 7:49 PM EDT
Intelligent Bio Solutions Revenue
In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%. Intelligent Bio Solutions had revenue of $843.88K in the quarter ending June 30, 2025, with 15.95% growth.
Revenue (ttm)
$3.05M
Revenue Growth
-1.90%
P/S Ratio
1.93
Revenue / Employee
$55,501
Employees
55
Market Cap
10.17M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
INBS News
- 1 day ago - Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance - GlobeNewsWire
- 10 days ago - Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator - GlobeNewsWire